TERT and hepatocellular carcinoma: Essentially, the distributions of the TERT*(rs2736098; c.915G > A) variant were significantly associated with elevated risk of HCC compared with control subjects under dominant [OR = 2.54, 95% CI = 1.43–4.53, P-value = 0.001], recessive [OR = 2.31, 95% CI = 1.01–5.27, P-value = 0.042], and homozygote [OR = 3.95, 95% CI = 1.58–9.85, P-value = 0.002] models.